Working… Menu

Evaluation of Dupilumab in Children With Uncontrolled Asthma (VOYAGE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02948959
Recruitment Status : Active, not recruiting
First Posted : October 31, 2016
Last Update Posted : October 14, 2019
Regeneron Pharmaceuticals
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : November 2020
Estimated Study Completion Date : November 2020